Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide for pre-oxygenation in cardiac surgery patients with pulmonary hypertension
2014-003338-15Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nitric oxide in pulmonary hypertension (PH), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Primary hemodynamic and respiratory parameters. Started Jun 2015; status: active.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2014-003338-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003338-15.